A new surveillance landscape for seasonal influenza? Comparing lab-confirmed influenza hospitalizations with other syndromic and surveillance data sources for the state of California.
White Lauren A LA, Sun Monica M, Burnor Elisabeth E, Murray Erin L EL et al.
During the COVID-19 pandemic, US federal hospitalization surveillance systems provided a new data source for lab-confirmed influenza hospital admissions; these data were important for monitoring hospital capacity for combined respiratory virus pathogen burden and served as a new forecasting target for seasonal influenza forecasting efforts. For influenza surveillance in the state of California, from February 2, 2022 through May 31, 2025, we explored: (1) how lab-confirmed hospital admissions correlated with other syndromic and sentinel surveillance data; (2) which signals could serve as potential leading signals relative to hospital admissions; and (3) how these relationships varied across respiratory virus seasons and geography. Despite varying across seasons and regions, influenza surveillance data sources in California were strongly correlated with laboratory-confirmed influenza hospitalizations (Spearman's P ≥ 0.8). These correlations generally strengthened through time from the 2021-2022 season to the most recent 2024-2025 season, especially for death, influenza-like illness, wastewater, and clinical lab data. Electronic laboratory reporting was the only data source to provide consistent leads of 1-2 weeks relative to the admissions signal across all four seasons (Spearman's P ≥ 0.89). Understanding the relationship between different data sources will improve situational awareness and help inform future estimates of influenza burden.